Virus-specific IgM and IgG antibody production by B cells during herpes simplex virus type 2-induced immunosuppression as analysed by an immunospot assay.

The mechanism of herpes simplex virus (HSV)-2-induced immunosuppression was analysed by determination of the number of IgM and IgG antibody-secreting B cells in female BALB/c mice using an immunospot assay. Primary HSV-1 or -2 as well as homologous or heterologous booster infections at different times were performed. In accordance with earlier results on humoral antibody generation, in contrast to HSV-1, HSV-2 induced only very low numbers of antibody-producing B cells in dose-response experiments. They appeared late after infection compared to HSV-1. Despite a homologous humoral booster reaction against HSV-1 at day 8 no IgM- or IgG-secreting cells in the spleen could be detected. This non-reactivity of the spleen had vanished 10 days later, when secondary reactions of B cells could be observed. Secondary infections with a high homologous dose of HSV-2 after a low primary dose produced only a low booster response of IgG-secreting B cells. Suppression of humoral antibody production induced by HSV-2 (high dose) waned after more than 50 days, indicating that the HSV-2-induced suppression did not impair antigen presentation or memory cell generation.

[1]  S. Nick,et al.  Suppression and enhancement of humoral antibody formation by herpes simplex virus types 1 and 2. , 1986, The Journal of general virology.

[2]  M. Dietrich,et al.  Differences in humoral immunogenicity between herpes simplex virus types 1 and 2. , 1985, The Journal of general virology.

[3]  D. Moskophidis,et al.  The immune response of the mouse to lymphocytic choriomeningitis virus. IV. Enumeration of antibody-producing cells in spleens during acute and persistent infection. , 1984, Journal of immunology.

[4]  W. Müller,et al.  Enhancement of antibody formation against herpes simplex virus in mice by the T-cell mitogen bestatin. , 1984, The Journal of general virology.

[5]  M. Krcmar,et al.  Prospective study on the relationship between cervical neoplasia and herpes simplex type‐2 virus. II. Herpes simplex type‐2 antibody presence in sera taken at enrolment , 1984 .

[6]  V. Dvorakova,et al.  Prospective study on the relationship between cervical neoplasia and herpes simplex type‐2 virus. I. Epidemiological characteristics , 1984, International journal of cancer.

[7]  P. Holt,et al.  A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. , 1983, Journal of immunological methods.

[8]  D. Falke,et al.  Kinetics and genetics of herpes simplex virus-induced antibody formation in mice , 1983, Infection and immunity.

[9]  W. Tompkins,et al.  Herpesvirus type 2: association with carcinoma of the cervix. , 1969, Science.

[10]  A. Nash,et al.  The T-Cell-Mediated Immune Response of Mice to Herpes Simplex Virus , 1985 .